Skip to main content
Equibles

Fisher Asset Management, LLC

Position in VCEL — Vericel Corp

CIK 850529 PLANO, TX
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$8,245,643
+$2,283,352 QoQ
Shares Held
185,337
0.0% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 317 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fisher Asset Management, LLC holds $807,507,065 across 59 Biotechnology names. VCEL ranks #26 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARWR
Arrowhead Pharmaceuticals, Inc.
 957,691 $78,061,393
2 RCUS
Arcus Biosciences, Inc.
 2,139,396 $65,957,578
3 CYTK
Cytokinetics Inc
 743,697 $63,355,547
4 DNLI
Denali Therapeutics Inc.
 2,414,162 $62,092,246
5 RVMD
Revolution Medicines, Inc.
 207,693 $38,896,745
6 LGND
Ligand Pharmaceuticals Inc
 121,440 $38,385,969
7 CLDX
Celldex Therapeutics, Inc.
 985,677 $36,677,041
8 HALO
Halozyme Therapeutics, Inc.
 427,713 $33,477,096

All Filings in VCEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,245,643 185,337
2026-03-31 $5,962,291 185,337
2025-12-31 $6,756,052 187,616
2025-09-30 $5,337,752 169,614
2025-06-30 $7,047,811 165,636
2025-03-31 $7,530,963 168,780
2024-12-31 $9,362,155 170,500
2024-09-30 $6,192,286 146,563
2024-06-30 $7,020,557 153,020
2024-03-31 $8,019,767 154,167
2023-12-31 $5,597,179 157,180
2023-09-30 $5,547,057 165,485
2023-06-30 $63,597,256 1,692,767
2023-03-31 $50,874,304 1,735,140
2022-12-31 $46,372,149 1,760,522
2022-09-30 $32,981,932 1,421,635
2022-06-30 $36,255,750 1,439,863
2022-03-31 $46,785,522 1,224,111
2021-12-31 $48,601,327 1,236,675
2021-09-30 $50,753,952 1,040,040
2021-06-30 $38,382,330 731,092
2021-03-31 $15,935,961 286,876
2020-12-31 $932,946 30,212
2020-09-30 $561,940 30,326